Markets:

Overview

News

Currencies

International

Treasuries

Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

14.60 +0.11 (+0.76%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amarin Corporation plc - American Depositary Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

LAWSUITS FILED AGAINST SAM, HYZN and AMRN - Jakubowitz Law Pursues Shareholders Claims

October 26, 2021

NEW YORK, NY / ACCESSWIRE / October 26, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

From Jakubowitz Law

Via AccessWire

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPLT, BMRN and AMRN

October 26, 2021

NEW YORK, NY / ACCESSWIRE / October 26, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...

From The Klein Law Firm

Via AccessWire

Topics Fraud Intellectual Property

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

October 26, 2021

From The Schall Law Firm

Via Business Wire

Analyzing Amarin Corp's Unusual Options Activity ↗

August 11, 2021

Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual opti...

Via Benzinga

Analyzing Amarin Corp's Unusual Options Activity ↗

August 05, 2021

Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual opti...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

SHAREHOLDER ALERT: HEPS BMRN AMRN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

October 26, 2021

NEW YORK, NY / ACCESSWIRE / October 26, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a...

From The Law Offices of Vincent Wong

Via AccessWire

Topics Fraud Intellectual Property Lawsuit

AMRN ALERT: Amarin Corporation plc Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

October 25, 2021

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

CORRECTING and REPLACING AMARIN CLASS ACTION NOTICE: The Schall Law Firm Files Securities Fraud Lawsuit Against Amarin Corporation, plc

October 25, 2021

From The Schall Law Firm

Via Business Wire

AMARIN ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Amarin Corporation PLC and Encourages Investors to Contact the Firm

October 25, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

AMARIN CLASS ACTION NOTICE: The Schall Law Firm Files Securities Fraud Lawsuit Against Amarin Corporation, plc

October 24, 2021

From The Schall Law Firm

Via Business Wire

Cramer Shares His Thoughts On Dynavax, Nucor And Amarin ↗

September 24, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said Dynavax Technologies Corporation (NASDAQ: DVAX) is good. He loves the immuno drug stories. Cramer said you are...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021 ↗

September 09, 2021

Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:

Via Benzinga

Amarin Stock Moves Higher As Vascepa Cuts Risk Of Heart Attacks ↗

August 23, 2021

Amarin Corporation plc (NASDAQ: AMRN) announced additional data on Vascepa/Vazkepa (icosapent ethyl) in patients with prior heart attack, known as myocardial...

Via Benzinga

Why Amarin Is Soaring Today ↗

August 05, 2021

The pharmaceuticals company is showing surprising resilience in the face of competition.

Via The Motley Fool

Topics Intellectual Property

77 Biggest Movers From Yesterday ↗

August 13, 2021

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to...

Via Benzinga

Amarin (AMRN) Q2 2021 Earnings Call Transcript ↗

August 05, 2021

AMRN earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: Amarin Q2 Earnings ↗

August 05, 2021

Shares of Amarin Corp (NASDAQ:AMRN) rose 0.7% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 100.00% over the...

Via Benzinga

Understanding Amarin Corp's Unusual Options Activity ↗

July 19, 2021

Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $4.22. Sentiment: BEARISH Option...

Via Benzinga

Why Amarin Fell Again Today ↗

June 22, 2021

Another Vascepa generic is launched in the U.S.

Via The Motley Fool

Topics Intellectual Property

48 Biggest Movers From Yesterday ↗

June 22, 2021

Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal ↗

June 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises 1.5%; Tarsus Pharmaceuticals Shares Slide ↗

June 21, 2021

Midway through trading Monday, the Dow traded up 1.48% to 33,782.47 while the NASDAQ rose 0.74% to 14,134.01. The S&P also rose, gaining 1.17% to 4,215.39. The U.S. has the...

Via Benzinga

Topics Stocks

31 Stocks Moving In Monday's Mid-Day Session ↗

June 21, 2021

Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share. Raven Industries, Inc. (NASDAQ: RAVN)...

Via Benzinga

Why Amarin Stock Is Sinking Today ↗

June 21, 2021

The biotech's attempt to revive Vascepa's U.S. patent protection appears to be at a dead end.

Via The Motley Fool

Topics Intellectual Property

Understanding Amarin Corp's Unusual Options Activity ↗

June 09, 2021

Amarin Corp (NASDAQ:AMRN) shares experienced unusual options activity on Wednesday. The stock price moved up to $5.02 following the option alert. Sentiment: BEARISH Option Type...

Via Benzinga

Market Briefing For Tuesday, Jun. 8 ↗

June 08, 2021

Benign market behavior generally persists; as an out-of-the-box rally effort to start Monday was reversed, as is typical since traders want a pullback first.

Via Talk Markets

Why Amarin Trounced the Market on Tuesday ↗

May 18, 2021

Investors reacted positively to a company presentation at an industry convention.

Via The Motley Fool

Why Amarin Stock Is Tumbling Today ↗

May 12, 2021

An analyst downgraded the drugmaker.

Via The Motley Fool

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.